{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T20:20:35Z","timestamp":1777494035789,"version":"3.51.4"},"reference-count":51,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"am","delay-in-days":365,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["R01 DA 039953"],"award-info":[{"award-number":["R01 DA 039953"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["T32 DA 041349"],"award-info":[{"award-number":["T32 DA 041349"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jpet.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"published-print":{"date-parts":[[2025,10]]},"DOI":"10.1016\/j.jpet.2025.103708","type":"journal-article","created":{"date-parts":[[2025,9,13]],"date-time":"2025-09-13T09:24:10Z","timestamp":1757755450000},"page":"103708","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Effects of the \u03bc-opioid peptide and nociceptin\/orphanin FQ peptide receptor agonist BU08028 on cocaine self-administration in male rhesus monkeys"],"prefix":"10.1016","volume":"392","author":[{"given":"Marissa B.","family":"Costa","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Miracle A.","family":"Collier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Phillip M.","family":"Epperly","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephen M.","family":"Husbands","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gerta","family":"Cami-Kobeci","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shoaib","family":"Manzoor","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1778-4625","authenticated-orcid":false,"given":"Paul W.","family":"Czoty","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.jpet.2025.103708_bib1","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1124\/pr.114.009209","article-title":"Nociceptin\/orphanin FQ receptor structure, signaling, functions, and interactions with opioid systems","volume":"68","author":"Toll","year":"2016","journal-title":"Pharmacol Rev"},{"issue":"15","key":"10.1016\/j.jpet.2025.103708_bib2","doi-asserted-by":"crossref","first-page":"7011","DOI":"10.1021\/acs.jmedchem.5b01499","article-title":"Nociceptin opioid receptor (NOP) as a therapeutic target: progress in translation from preclinical research to clinical utility","volume":"59","author":"Zaveri","year":"2016","journal-title":"J Med Chem"},{"issue":"2","key":"10.1016\/j.jpet.2025.103708_bib3","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1021\/cn300124f","article-title":"The therapeutic potential of nociceptin\/orphanin FQ receptor agonists as analgesics without abuse liability","volume":"4","author":"Lin","year":"2013","journal-title":"ACS Chem Neurosci"},{"issue":"3","key":"10.1016\/j.jpet.2025.103708_bib4","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1124\/jpet.110.175620","volume":"336","author":"Khroyan","year":"2011","journal-title":"J Pharmacol Exp Ther"},{"issue":"8","key":"10.1016\/j.jpet.2025.103708_bib5","doi-asserted-by":"crossref","first-page":"1476","DOI":"10.1038\/s41386-019-0390-z","article-title":"Effects of stimulation of mu opioid and nociceptin\/orphanin FQ peptide (NOP) receptors on alcohol drinking in rhesus monkeys","volume":"44","author":"Flynn","year":"2019","journal-title":"Neuropsychopharmacology"},{"issue":"6","key":"10.1016\/j.jpet.2025.103708_bib6","doi-asserted-by":"crossref","DOI":"10.1111\/adb.12844","article-title":"Potent and selective NOP receptor activation reduces cocaine self-administration by lowering hedonic set point","volume":"25","author":"Cippitelli","year":"2020","journal-title":"Addict Biol"},{"key":"10.1016\/j.jpet.2025.103708_bib7","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuropharm.2022.109045","article-title":"PPL-138 (BU10038): a bifunctional NOP\/mu partial agonist that reduces cocaine self-administration in rats","volume":"211","author":"Cippitelli","year":"2022","journal-title":"Neuropharmacology"},{"issue":"37","key":"10.1016\/j.jpet.2025.103708_bib8","doi-asserted-by":"crossref","first-page":"E5511","DOI":"10.1073\/pnas.1605295113","article-title":"A novel orvinol analog, BU08028, as a safe opioid analgesic without abuse liability in primates","volume":"113","author":"Ding","year":"2016","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"456","key":"10.1016\/j.jpet.2025.103708_bib9","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aar3483","article-title":"A bifunctional nociceptin and mu opioid receptor agonist is analgesic without opioid side effects in nonhuman primates","volume":"10","author":"Ding","year":"2018","journal-title":"Sci Transl Med"},{"issue":"6","key":"10.1016\/j.jpet.2025.103708_bib10","doi-asserted-by":"crossref","first-page":"e146","DOI":"10.1016\/j.bja.2018.10.065","article-title":"BU10038 as a safe opioid analgesic with fewer side effects after systemic and intrathecal administration in primates","volume":"122","author":"Kiguchi","year":"2019","journal-title":"Br J Anaesth"},{"issue":"4","key":"10.1016\/j.jpet.2025.103708_bib11","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1037\/1064-1297.15.4.309","article-title":"The value of nonhuman primates in drug abuse research","volume":"15","author":"Weerts","year":"2007","journal-title":"Exp Clin Psychopharmacol"},{"issue":"9","key":"10.1016\/j.jpet.2025.103708_bib12","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1002\/ajp.22281","article-title":"Why primate models matter","volume":"76","author":"Phillips","year":"2014","journal-title":"Am J Primatol"},{"issue":"8","key":"10.1016\/j.jpet.2025.103708_bib13","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1038\/nn1737","article-title":"PET imaging of dopamine D2 receptors during chronic cocaine self-administration in monkeys","volume":"9","author":"Nader","year":"2006","journal-title":"Nat Neurosci"},{"issue":"2","key":"10.1016\/j.jpet.2025.103708_bib14","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1002\/syn.890140210","article-title":"Decreased dopamine D2 receptor availability is associated with reduced frontal metabolism in cocaine abusers","volume":"14","author":"Volkow","year":"1993","journal-title":"Synapse"},{"issue":"1\u20132","key":"10.1016\/j.jpet.2025.103708_bib15","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/S0006-8993(00)02669-X","article-title":"Autoradiographic localization of [3H] nociceptin binding sites in the rat brain","volume":"880","author":"Florin","year":"2000","journal-title":"Brain Res"},{"issue":"10","key":"10.1016\/j.jpet.2025.103708_bib16","doi-asserted-by":"crossref","first-page":"1638","DOI":"10.2967\/jnumed.111.091181","article-title":"Brain and whole-body imaging in rhesus monkeys of 11C-NOP-1A, a promising PET radioligand for nociceptin\/orphanin FQ peptide receptors","volume":"52","author":"Kimura","year":"2011","journal-title":"J Nucl Med"},{"key":"10.1016\/j.jpet.2025.103708_bib17","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.neuroimage.2012.11.053","article-title":"Evaluation of [18F]MK-0911, a positron emission tomography (PET) tracer for opioid receptor-like 1 (ORL1), in rhesus monkey and human","volume":"68","author":"Hostetler","year":"2013","journal-title":"Neuroimage"},{"issue":"10","key":"10.1016\/j.jpet.2025.103708_bib18","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1016\/j.biopsych.2017.05.019","article-title":"Nociceptin receptors in alcohol use disorders: a positron emission tomography study using [11C]NOP-1A","volume":"84","author":"Narendran","year":"2018","journal-title":"Biol Psychiatry"},{"issue":"3","key":"10.1016\/j.jpet.2025.103708_bib19","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1124\/jpet.109.157446","article-title":"Comparison of the antinociceptive and anti-rewarding profiles of novel bifunctional nociceptin receptor\/mu-opioid receptor ligands: implications for therapeutic applications","volume":"331","author":"Toll","year":"2009","journal-title":"J Pharmacol Exp Ther"},{"issue":"2","key":"10.1016\/j.jpet.2025.103708_bib20","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1038\/npp.2010.185","article-title":"Prolonged attenuation of the reinforcing strength of cocaine by chronic d-amphetamine treatment in rhesus monkeys","volume":"36","author":"Czoty","year":"2011","journal-title":"Neuropsychopharmacology"},{"issue":"3","key":"10.1016\/j.jpet.2025.103708_bib21","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1124\/jpet.113.204321","article-title":"Effects of chronic methylphenidate on cocaine self-administration under a progressive-ratio schedule of reinforcement in rhesus monkeys","volume":"345","author":"Czoty","year":"2013","journal-title":"J Pharmacol Exp Ther"},{"issue":"3","key":"10.1016\/j.jpet.2025.103708_bib22","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1124\/pr.115.011668","article-title":"Evaluation of the \u201cpipeline\u201d for development of medications for cocaine use disorder: a review of translational preclinical, human laboratory and clinical trial research","volume":"68","author":"Czoty","year":"2016","journal-title":"Pharmacol Rev"},{"issue":"2","key":"10.1016\/j.jpet.2025.103708_bib23","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1124\/jpet.111.185538","article-title":"Effects of varenicline on the reinforcing and discriminative stimulus effects of cocaine in rhesus monkeys","volume":"339","author":"Gould","year":"2011","journal-title":"J Pharmacol Exp Ther"},{"issue":"3","key":"10.1016\/j.jpet.2025.103708_bib24","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1124\/jpet.117.241042","article-title":"Cebranopadol blocks the escalation of cocaine intake and conditioned reinstatement of cocaine seeking in rates","volume":"362","author":"de Gugliemo","year":"2017","journal-title":"J Pharmacol Exp Ther"},{"issue":"2","key":"10.1016\/j.jpet.2025.103708_bib25","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1111\/adb.12513","article-title":"Buprenorphine requires concomitant activation of NOP and MOP receptors to reduce cocaine consumption","volume":"23","author":"Kallupi","year":"2018","journal-title":"Addict Biol"},{"issue":"3","key":"10.1016\/j.jpet.2025.103708_bib26","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1007\/s00213-003-1601-0","article-title":"Do vertical shifts in dose-response rate-relationships in operant conditioning procedures indicate \u201csensitization\u201d to \u201cdrug wanting\u201d","volume":"171","author":"Zernig","year":"2004","journal-title":"Psychopharmacology (Berl)"},{"issue":"3","key":"10.1016\/j.jpet.2025.103708_bib27","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1124\/jpet.300.3.1111","article-title":"Effects of mu-opioid agonists on cocaine- and food-maintained responding and cocaine discrimination in rhesus monkeys: role of mu-agonist efficacy","volume":"300","author":"Negus","year":"2002","journal-title":"J Pharmacol Exp Ther"},{"issue":"7","key":"10.1016\/j.jpet.2025.103708_bib28","doi-asserted-by":"crossref","first-page":"1462","DOI":"10.1038\/sj.npp.1300927","article-title":"Effects of high-dose methadone maintenance on cocaine place conditioning, cocaine self-administration, and mu-opioid receptor mRNA expression in the rat brain","volume":"31","author":"Leri","year":"2006","journal-title":"Neuropsychopharmacology"},{"issue":"3","key":"10.1016\/j.jpet.2025.103708_bib29","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1007\/s00213-003-1409-y","article-title":"Effects of chronic d-amphetamine treatment on cocaine- and food-maintained responding under a progressive-ratio schedule in rhesus monkeys","volume":"167","author":"Negus","year":"2003","journal-title":"Psychopharmacology (Berl)"},{"issue":"1","key":"10.1016\/j.jpet.2025.103708_bib30","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/S0376-8716(02)00339-3","article-title":"Effects of chronic d-amphetamine treatment on cocaine- and food-maintained responding under a second-order schedule in rhesus monkeys","volume":"70","author":"Negus","year":"2003","journal-title":"Drug Alcohol Depend"},{"issue":"3","key":"10.1016\/j.jpet.2025.103708_bib31","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1007\/s00213-009-1622-4","article-title":"Decreased reinforcing effects of cocaine following 2 weeks of continuous d-amphetamine treatment in rats","volume":"206","author":"Chiodo","year":"2009","journal-title":"Psychopharmacology (Berl)"},{"issue":"2","key":"10.1016\/j.jpet.2025.103708_bib32","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1007\/BF00432175","article-title":"Reinstatement of cocaine-reinforced responding in the rat","volume":"75","author":"de Wit","year":"1981","journal-title":"Psychopharmacology (Berl)"},{"issue":"Suppl 1","key":"10.1016\/j.jpet.2025.103708_bib33","first-page":"256","article-title":"Effects of dopamine indirect agonists and selective D1-like and D2-like agonists and antagonists on cocaine self-administration and food maintained responding in rats","volume":"47","author":"Barrett","year":"2004","journal-title":"Neuropsychopharmacology"},{"issue":"2","key":"10.1016\/j.jpet.2025.103708_bib34","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1124\/jpet.108.145813","article-title":"Assessment of reinforcing effects of benztropine analogs and their effects on cocaine self-administration in rats: comparisons with monoamine uptake inhibitors","volume":"329","author":"Hiranita","year":"2009","journal-title":"J Pharmacol Exp Ther"},{"issue":"12","key":"10.1016\/j.jpet.2025.103708_bib35","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1001\/archpsyc.56.12.1101","article-title":"Attenuation of the euphoric effects of cocaine by the dopamine D1\/D5 antagonist ecopipam (SCH 39166)","volume":"56","author":"Romach","year":"1999","journal-title":"Arch Gen Psychiatry"},{"issue":"4","key":"10.1016\/j.jpet.2025.103708_bib36","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1007\/s002130100725","article-title":"Effects of ecopipam, a selective dopamine D1 antagonist, on smoked cocaine self-administration by humans","volume":"155","author":"Haney","year":"2001","journal-title":"Psychopharmacology (Berl)"},{"issue":"6","key":"10.1016\/j.jpet.2025.103708_bib37","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1037\/a0014398","article-title":"Medications for stimulant abuse: agonist-based strategies and preclinical evaluation of the mixed-action D2 partial agonist aripiprazole (Abilify)","volume":"16","author":"Bergman","year":"2008","journal-title":"Exp Clin Psychopharmacol"},{"issue":"1","key":"10.1016\/j.jpet.2025.103708_bib38","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1007\/s00213-008-1245-1","article-title":"Effects of acute and chronic aripiprazole treatment on choice between cocaine self-administration and food under a concurrent schedule of reinforcement in rats","volume":"201","author":"Thomsen","year":"2008","journal-title":"Psychopharmacology (Berl)"},{"issue":"6","key":"10.1016\/j.jpet.2025.103708_bib39","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1176\/appi.ajp.2019.18081007","article-title":"Nociceptin receptors upregulated in cocaine use disorder: a positron emission tomography imaging study using [11C]NOP-1A","volume":"176","author":"Narendran","year":"2019","journal-title":"Am J Psychiatry"},{"issue":"2","key":"10.1016\/j.jpet.2025.103708_bib40","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1007\/s00213-002-1183-2","article-title":"Biological basis of sex differences in drug abuse: preclinical and clinical studies","volume":"164","author":"Lynch","year":"2002","journal-title":"Psychopharmacology (Berl)"},{"issue":"3","key":"10.1016\/j.jpet.2025.103708_bib41","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1016\/S0306-4522(02)01000-X","article-title":"Sex-related differences in the distribution of opioid receptor-like 1 receptor mRNA and colocalization with estrogen receptor mRNA in neurons of the spinal trigeminal nucleus caudalis in the rat","volume":"118","author":"Flores","year":"2003","journal-title":"Neuroscience"},{"issue":"3","key":"10.1016\/j.jpet.2025.103708_bib42","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/j.neuropharm.2012.04.028","article-title":"Sex differences in the nociceptin\/orphanin FQ system in the rat spinal cord following chronic morphine treatment","volume":"63","author":"Zhang","year":"2012","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.jpet.2025.103708_bib43","doi-asserted-by":"crossref","DOI":"10.1016\/j.pbb.2024.173845","article-title":"Age- and sex-driven alterations in alcohol consumption patterns: role of brain ethanol metabolism and the opioidergic system in the nucleus accumbens","volume":"244","author":"Cuitavi","year":"2024","journal-title":"Pharmacol Biochem Behav"},{"issue":"7","key":"10.1016\/j.jpet.2025.103708_bib44","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.1111\/bph.14915","article-title":"NOP receptor antagonism reduces alcohol drinking in male and female rats through mechanisms involving the central amygdala and ventral tegmental area","volume":"177","author":"Borruto","year":"2020","journal-title":"Br J Pharmacol"},{"issue":"12","key":"10.1016\/j.jpet.2025.103708_bib45","doi-asserted-by":"crossref","first-page":"2121","DOI":"10.1038\/s41386-021-01096-1","article-title":"NOP receptor antagonism attenuates reinstatement of alcohol-seeking through modulation of the mesolimbic circuitry in male and female alcohol-preferring rats","volume":"46","author":"Borruto","year":"2021","journal-title":"Neuropsychopharmacology"},{"issue":"12","key":"10.1016\/j.jpet.2025.103708_bib46","doi-asserted-by":"crossref","first-page":"2497","DOI":"10.1007\/s00213-024-06678-7","article-title":"Effect of chronic delivery of the NOP\/MOR partial agonist AT-201 and NOP antagonist J-113397 on heroin relapse in a rat model of opioid maintenance","volume":"241","author":"Bossert","year":"2024","journal-title":"Psychopharmacology (Berl)"},{"issue":"2","key":"10.1016\/j.jpet.2025.103708_bib47","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1111\/bph.15679","article-title":"Sex differences in the effect of chronic delivery of the buprenorphine analogue BU08028 on heroin relapse and choice in a rat model of opioid maintenance","volume":"179","author":"Bossert","year":"2022","journal-title":"Br J Pharmacol"},{"issue":"6","key":"10.1016\/j.jpet.2025.103708_bib48","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1016\/j.biopsych.2019.09.013","article-title":"Acute elevations in cortisol increase the in vivo binding of [11C]NOP-1A to nociceptin receptors: a novel imaging paradigm to study the interaction between stress- and antistress-regulating neuropeptides","volume":"87","author":"Flanigan","year":"2020","journal-title":"Biol Psychiatry"},{"issue":"5","key":"10.1016\/j.jpet.2025.103708_bib49","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1016\/j.biopsych.2022.12.022","article-title":"Imaging nociceptin opioid peptide receptors in alcohol use disorder with [11C]NOP-1A and positron emission tomography: findings form a second cohort","volume":"94","author":"Tollefson","year":"2023","journal-title":"Biol Psychiatry"},{"issue":"9","key":"10.1016\/j.jpet.2025.103708_bib50","doi-asserted-by":"crossref","first-page":"1935","DOI":"10.1111\/acer.13147","article-title":"Proof-of-concept study to assess the nociceptin receptor agonist LY2940094 as a new treatment for alcohol dependence","volume":"40","author":"Post","year":"2016","journal-title":"Alcohol Clin Exp Res"},{"issue":"2","key":"10.1016\/j.jpet.2025.103708_bib51","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.tips.2016.11.002","article-title":"Insights from preclinical choice models of treating drug addiction","volume":"38","author":"Banks","year":"2017","journal-title":"Trends Pharmacol Sci"}],"container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022356525402213?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022356525402213?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T18:57:09Z","timestamp":1761850629000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022356525402213"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10]]},"references-count":51,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2025,10]]}},"alternative-id":["S0022356525402213"],"URL":"https:\/\/doi.org\/10.1016\/j.jpet.2025.103708","relation":{},"ISSN":["0022-3565"],"issn-type":[{"value":"0022-3565","type":"print"}],"subject":[],"published":{"date-parts":[[2025,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effects of the \u03bc-opioid peptide and nociceptin\/orphanin FQ peptide receptor agonist BU08028 on cocaine self-administration in male rhesus monkeys","name":"articletitle","label":"Article Title"},{"value":"The Journal of Pharmacology and Experimental Therapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jpet.2025.103708","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 American Society for Pharmacology and Experimental Therapeutics. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"103708"}}